Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells

Experimental Cell Research

Volumn 304, Issue 2, 2005, Pages 354-364

  Mazières, Julien ^a   Tillement, Vanessa ^a   Allal, Cuider ^a   Clanet, Carine ^a   Bobin, Lisbeth ^a   Chen, Zhi ^b,c   Sebti, Said M ^b,c   Favre, Gilles ^a   Pradines, Anne ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Oncogenesis; Prenylation; Ras; RhoB

Indexed keywords

GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PROTEIN KINASE B; RAS PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CELL ANCHORAGE; CELL GROWTH; CELL STRAIN 3T3; CONTROLLED STUDY; FEMALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 14644402451     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.10.019     Document Type: Article

References (64)

1. L. Lim, E. Manser, T. Leung, and C. Hall Regulation of phosphorylation pathways by p21 GTPases-The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways Eur. J. Biochem. 242 1996 171 185
2. L. Van Aelst, and C. D'Souza-Schorey Rho GTPases and signaling networks Genes Dev. 11 1997 2295 2322
3. F.L. Zhang, and P.J. Casey Protein prenylation: molecular mechanisms and functional consequences Annu. Rev. Biochem. 65 1996 241 269
4. R. Foster, K.Q. Hu, Y. Lu, K.M. Nolan, J. Thissen, and J. Settleman Identification of a novel human rho protein with unusual properties: GTPase deficiency and in vivo farnesylation Mol. Cell. Biol. 16 1996 2689 2699
5. K. Yokoyama, G.W. Goodwin, F. Ghomashchi, J.A. Glomset, and M.H. Gelb A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity Proc. Natl. Acad. Sci. U. S. A. 88 1991 5302 5306
6. K. Yokoyama, and M.H. Gelb Purification of a mammalian protein geranylgeranyltransferase-Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex J. Biol. Chem. 268 1993 4055 4060
7. P. Adamson, C.J. Marshall, A. Hall, and P.A. Tilbrook Post-translational modifications of p21rho proteins J. Biol. Chem. 267 1992 20033 20038
8. P.F. Lebowitz, P.J. Casey, G.C. Prendergast, and J.A. Thissen Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB J. Biol. Chem. 272 1997 15591 15594
9. R. Baron, E. Fourcade, I. Lajoie-Mazenc, C. Allal, B. Couderc, R. Barbaras, G. Favre, J.C. Faye, and A. Pradines RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody Proc. Natl. Acad. Sci. U. S. A. 97 2000 11626 11631
10. D. Robertson, H.F. Paterson, P. Adamson, A. Hall, and P. Monaghan Ultrastructural localization of ras-related proteins using epitope-tagged plasmids J. Histochem. Cytochem. 43 1995 471 480
11. P. Adamson, H.F. Paterson, and A. Hall Intracellular localization of the p21Rho proteins J. Cell Biol. 119 1992 617 627
12. M. Wherlock, A. Gampel, C. Futter, and H. Mellor Farnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase J. Cell Sci. 117 2004 3221 3231
13. D. Michaelson, J. Silletti, G. Murphy, P. D'Eustachio, M. Rush, and M.R. Philips Differential localization of Rho GTPases in live cells. Regulation by hypervariable regions and rhogdi binding J. Cell Biol. 152 2001 111 126
14. M.E. Engel, P.K. Datta, and H.L. Moses RhoB is stabilized by TGFβ and antagonizes transcriptional activation J. Biol. Chem. 273 1998 9921 9926
15. G. Zalcman, V. Closson, G. Linarescruz, F. Lerebours, N. Honore, A. Tavitian, and B. Olofsson Regulation of ras-related RhoB protein expression during the cell cycle Oncogene 10 1995 1935 1945
16. P. De Cremoux, C. Gauville, V. Closson, G. Linares, F. Calvo, A. Tavitian, and B. Olofsson EGF modulation of the ras-related rhoB gene expression in human breast-cancer cell lines Int. J. Cancer 59 1994 408 415
17. A. Moustakas, and C. Stournaras Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts J. Cell Sci. 112 1999 1169 1179
18. G. Fritz, B. Kaina, and K. Aktories The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments J. Biol. Chem. 270 1995 25172 25177
19. D. Jahner, and T. Hunter The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts Mol. Cell. Biol. 11 1991 3682 3690
20. P.F. Lebowitz, J.P. Davide, and G.C. Prendergast Evidence that farnesyltransferase inhibitors suppress ras transformation by interfering with rho activity Mol. Cell. Biol. 15 1995 6613 6622
21. S.L. Campbell, R. KhosraviFar, K.L. Rossman, G.J. Clark, and C.J. Der Increasing complexity of Ras signaling Oncogene 17 1998 1395 1413
22. I.M. Zohn, S.L. Campbell, R. KhosraviFar, K.L. Rossman, and C.J. Der Rho family proteins and Ras transformation: the RHOad less traveled gets congested Oncogene 17 1998 1415 1438
23. A. Gampel, P.J. Parker, and H. Mellor Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB Curr. Biol. 9 1999 955 958
24. G. Fritz, and B. Kaina Ras-related GTPase RhoB forces alkylation-induced apoptotic cell death Biochem. Biophys. Res. Commun. 268 2000 784 789
25. A. Liu, G.J. Cerniglia, E.J. Bernhard, and G.C. Prendergast RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage Proc. Natl. Acad. Sci. U. S. A. 98 2001 6192 6197
26. R. Perona, S. Montaner, L. Saniger, I. Sanchez-Perez, R. Bravo, and J.C. Lacal Activation of the nuclear factor-kB by Rho, CDC42, and Rac-1 proteins Genes Dev. 11 1997 463 475
27. G. Fritz, and B. Kaina Ras-related GTPase RhoB represses NF-kB signaling J. Biol. Chem. 276 2001 3115 3122
28. M.F. Olson, A. Ashworth, and A. Hall An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1 Science 269 1995 1270 1272
29. R. Perona, P. Esteve, B. Jimenez, R.P. Ballestero, S. Ramon y Cajal, and J.C. Lacal Tumorigenic activity of rho genes from Aplysia californica Oncogene 8 1993 1285 1292
30. R. Khosravi-Far, P.A. Solski, G.J. Clark, M.S. Kinch, and C.J. Der Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation Mol. Cell. Biol. 15 1995 6443 6453
31. R.G. Qiu, J. Chen, D. Kirn, F. Mccormick, and M. Symons An essential role for rac in ras transformation Nature 374 1995 457 459
32. R.G. Qiu, J. Chen, F. Mccormick, and M. Symons A role for rho in ras transformation Proc. Natl. Acad. Sci. U. S. A. 92 1995 11781 11785
33. R.G. Qiu, A. Abo, F. McCormick, and M. Symons Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation Mol. Cell. Biol. 17 1997 3449 3458
34. G.C. Prendergast, R. Khosravi-Far, P.A. Solski, H. Kurzawa, P.F. Lebowitz, and C.J. Der Critical role of rho in cell transformation by oncogenic ras Oncogene 10 1995 2289 2296
35. P.F. Lebowitz, W. Du, and G.C. Prendergast Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription J. Biol. Chem. 272 1997 16093 16095
36. W. Du, and G.C. Prendergast Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors Cancer Res. 59 1999 5492 5496
37. Z. Chen, J. Sun, A. Pradines, G. Favre, J. Adnane, and S.M. Sebti Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation, induce apoptosis and suppress human tumor growth in nude mice J. Biol. Chem. 275 2000 17974 17978
38. J. Adnane, C. Muro-Cacho, L. Mathews, S.M. Sebti, and T. Munoz-Antonia Suppression of rho B expression in invasive carcinoma from head and neck cancer patients Clin. Cancer Res. 8 2002 2225 2232
39. J. Mazieres, T. Antonia, G. Daste, C. Muro-Cacho, D. Berchery, V. Tillement, A. Pradines, S. Sebti, and G. Favre Loss of RhoB expression in human lung cancer progression Clin. Cancer Res. 10 2004 2742 2750
40. K. Jiang, F.L. Delarue, and S.M. Sebti EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation Oncogene 23 2004 1136 1145
41. W. Du, P.F. Lebowitz, and G.C. Prendergast Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB Mol. Cell. Biol. 19 1999 1831 1840
42. M. Berton, S. Sixou, R. Kravtzoff, C. Dartigues, L. Imbertie, C. Allal, and G. Favre Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular Bio Vector (SMBV) Biochim. Biophys. Acta 1355 1997 7 19
43. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd New colorimetric cytotoxicity assay for anticancer drug screening J. Natl. Cancer Inst. 82 1990 1107 1112
44. E.A. Lerner, T.-T. Zhang, D.B. Knowles, Y. Qian, A.D. Hamilton, and S.M. Sebti Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitors in human tumor cell lines Oncogene 15 1997 1283 1288
45. T. Okamoto, A. Schlegel, P.E. Scherer, and M.P. Lisanti Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane J. Biol. Chem. 273 1998 5419 5422
46. A.J. Koleske, D. Baltimore, and M.P. Lisanti Reduction of caveolin and caveolae in oncogenically transformed cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 1381 1385
47. C. Racine, M. Belanger, H. Hirabayashi, M. Boucher, J. Chakir, and J. Couet Reduction of caveolin 1 gene expression in lung carcinoma cell lines Biochem. Biophys. Res. Commun. 255 1999 580 586
48. J. Pouyssegur, V. Volmat, and P. Lenormand Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling Biochem. Pharmacol. 64 2002 755 763
49. A.X. Liu, N. Rane, J.P. Liu, and G.C. Prendergast RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells Mol. Cell. Biol. 21 2001 6906 6912
50. R. Khosravi-Far, M.A. White, J.K. Westwick, P.A. Solski, M. Chrzanowskawodnicka, L. Vanaelst, M.H. Wigler, and C.J. Der Oncogenic ras activation of raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation Mol. Cell. Biol. 16 1996 3923 3933
51. A. Liu, and G.C. Prendergast Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors FEBS Lett. 481 2000 205 208
52. A. Liu, W. Du, J.P. Liu, T.M. Jessell, and G.C. Prendergast RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors Mol. Cell. Biol. 20 2000 6105 6113
53. I. Adini, I. Rabinovitz, J.F. Sun, G.C. Prendergast, and L.E. Benjamin RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development Genes Dev. 17 2003 2721 2732
54. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 274 1996 784 787
55. T. Trapp, L. Olah, I. Holker, M. Besselmann, C. Tiesler, K. Maeda, and K.A. Hossmann GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice Mol. Cell. Neurosci. 17 2001 883 894
56. E.J. Bernhard RhoB and the cellular response to farnesyltransferase inhibitors: the search for clues to cell death mechanisms Cancer Biol. Ther. 2 2003 281 282
57. K. Jiang, J. Sun, J. Cheng, J.Y. Djeu, S. Wei, and S. Sebti Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis Mol. Cell. Biol. 24 2004 5565 5576
58. P.Y. Zeng, N. Rane, W. Du, J. Chintapalli, and G.C. Prendergast Role for RhoB and PRK in the suppression of epithelial cell transformation by farnesyltransferase inhibitors Oncogene 22 2003 1124 1134
59. P. Flynn, H. Mellor, A. Casamassima, and P.J. Parker Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide- dependent protein kinase J. Biol. Chem. 275 2000 11064 11070
60. M.J. Wick, L.Q. Dong, R.A. Riojas, F.J. Ramos, and F. Liu Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1 J. Biol. Chem. 275 2000 40400 40406
61. C.S. Myung, H. Yasuda, W.W. Liu, T.K. Harden, and J.C. Garrison Role of isoprenoid lipids on the heterotrimeric G protein gamma subunit in determining effector activation J. Biol. Chem. 274 1999 16595 16603
62. X. Jian, W.A. Clark, J. Kowalak, S.P. Markey, W.F. Simonds, and J.K. Northup G beta gamma affinity for bovine rhodopsin is determined by the carboxyl-terminal sequences of the gamma subunit J. Biol. Chem. 276 2001 48518 48525
63. A.D. Cox, A.M. Garcia, J.K. Westwick, J.J. Kowalczyk, M.D. Lewis, D.A. Brenner, and C.J. Der The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation J. Biol. Chem. 269 1994 19203 19206
64. C. Allal, G. Favre, B. Couderc, S. Salicio, S. Sixou, A.D. Hamilton, S.M. Sebti, I. Lajoie-Mazenc, and A. Pradines RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription J. Biol. Chem. 275 2000 31001 31008